Quick10K

⚲

1847 Holdings

Filings

S-1	2020-10-30	Public Filing
10-Q	2020-09-30	Filed 2020-11-23
10-Q	2020-06-30	Filed 2020-08-14
10-Q	2020-03-31	Filed 2020-05-15
S-1	2020-01-23	Public Filing
10-K	2019-12-31	Filed 2020-03-30
10-Q	2019-09-30	Filed 2019-11-19
10-Q	2019-06-30	Filed 2019-08-19
10-Q	2019-03-31	Filed 2019-05-15
10-K	2018-12-31	Filed 2019-04-15
10-Q	2018-09-30	Filed 2018-11-19
10-Q	2018-06-30	Filed 2018-08-17
10-Q	2018-03-31	Filed 2018-05-21
10-K	2017-12-31	Filed 2018-04-17
10-Q	2017-09-30	Filed 2017-11-14
10-Q	2017-06-30	Filed 2017-08-21
10-Q	2017-03-31	Filed 2017-05-22
10-K	2016-12-31	Filed 2017-04-17
10-Q	2016-09-30	Filed 2016-11-21
10-Q	2016-06-30	Filed 2016-08-22
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-04-14
10-Q	2015-09-30	Filed 2015-11-23
10-Q	2015-06-30	Filed 2015-08-19
10-Q	2015-03-31	Filed 2015-05-15
10-K	2014-12-31	Filed 2015-04-15
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-08-19
10-Q	2014-03-31	Filed 2014-06-23

Reports

8-K	2021-02-09	Enter Agreement
8-K	2021-01-14	Officers, Exhibits
8-K	2020-12-22	Enter Agreement
8-K	2020-12-07	Enter Agreement, Off-BS Arrangement, Exhibits
8-K	2020-11-20	Enter Agreement, Exhibits
8-K	2020-10-26
8-K	2020-10-23
8-K	2020-10-20
8-K	2020-10-20
8-K	2020-09-30
8-K	2020-09-25
8-K	2020-08-28
8-K	2020-08-27
8-K	2020-08-25
8-K	2020-07-30
8-K	2020-07-29
8-K	2020-07-17
8-K	2020-05-28
8-K	2020-05-11
8-K	2020-03-27
8-K	2019-09-24
8-K	2019-07-12
8-K	2019-07-10
8-K	2019-05-31
8-K	2019-04-05
8-K	2019-03-13
8-K	2019-01-18
8-K	2018-11-12
8-K	2018-06-13
8-K	2018-05-10
8-K	2018-04-18
8-K	2018-01-19
8-K	2018-01-03

1847 Holdings Financials

EFSH Metrics, Comps, Filings

Quarterly | Annual

Valuation ($MM)

Market Cap, Enterprise Value

Balance Sheet ($MM)

Assets, Equity

Income Statement ($MM Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($MM Quarterly)

Ops, Inv, Fin


Comps ($'000 TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546,418	322,654	0	0	0	0	-853,740
1 800 Flowers Com (FLWS)	944,324	42%	13.3	6%	664,955	335,559	1,266,390	533,727	36,761	75,090	1,000,932
10x Genomics (TXG)	4,804,979	75%	-490.3	-2%	572,815	151,367	61,207	45,727	-9,603	-8,887	4,357,180
12 Retech (RETC)	0	32%	-0.1	-1,385%	1,118	20,421	625	199	-15,491	-14,800	966
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	33,711	0%	0.4	-5%	164,088	108,405	18,194	0	-7,969	-8,017	-2,855
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	18,527	23,194	27,219	6,699	-2,862	-1,433	3,396
1895 Bancorp of Wisconsin (BCOW)	46,152,715		12,508.1	-0%	441,187	382,722	0	0	-44	3,689	46,142,359
1st Constitution Bancorp (FCCY)	164,504	0%	4.4	1%	1,342,565	1,204,038	490	0	13,787	32,503	143,748
1st Franklin Financial (FFC)	3,551		-0.6	7%	905,107	644,730	0	0	62,078	80,004	-45,962
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200,033		7.9	1%	6,691,070	5,858,028	0	0	70,061	136,342	1,072,548
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	1,849	0	0	-1,663	-1,654	250
21Vianet Group (VNET)	6,005,116			0%	11,150,717	5,787,533	0	0	0	0	3,344,095
22nd Century (XXII)	301,854	1%	-14.1	-36%	61,864	6,554	25,706	304	-22,433	-21,464	301,826
1Life Healthcare (ONEM)


Balance Sheet ($'000)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-06-30	2019-09-30
Cash	0	13	0	0	0	0	0	0	0	0	0	0	169	287	501	78	98	9	334	318	197
Accounts Receivable	25	38	50	62	75	88	100	100	100	100	100	0	300	261	310	94	299	245	550	2,588	1,790
Inventory												0	562	566	837	771	747	858	488	2,688	2,571
PP&E													6,539	7,429	7,213	7,128	6,954	6,954	6,931	7,129	7,132
Assets	40	51	57	63	75	113	101	101	101	100	100	0	8,067	7,904	8,084	6,949	6,595	6,355	6,052	19,469	18,527
Accounts Payable
Long-Term Debt													4,381	324	58	55	3,503	3,297	3,262	3,822	3,593
Liabilities	53	128	148	252	305	385	454	501	540	584	628	670	7,170	9,654	8,570	8,228	8,298	8,485	8,079	22,957	23,194
Stockholders' Equity	-13	-77	-91	-189	-230	-272	-353	-400	-439	-484	-528	-670	1,287	-1,202	-485	-1,278	-1,703	-2,130	-2,027	-3,488	-4,668


Income Statement ($'000)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-06-30	2019-09-30
Revenue	44	44	44	44	44	44	44	0	0	0	0	0	1,788	1,205	2,756	763	1,470	1,467		12,208	13,544
Cost of Revenue												-181	1,553	1,563				478		9,332	10,710
Gross Profit												181	235	-358				988		2,876	2,835
R&D
SG&A	44	44	45	45	45	45	46	2	2	2	2	102	803	695	506	535	375	281		1,711	1,964
Tax	0	0	0	0	0	0	0	0	0	0	0	0	0	-407	-424	0	0	0		-5	-396
Net Income	-2	-64	-14	-98	-41	-42	-81	-47	-39	-45	-44	-142	1,611	-745	413	-793	-425	-426		-1,256	-1,180


Cash Flow ($'000)	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-06-30	2017-09-30	2017-12-31	2018-03-31	2018-06-30	2018-09-30	2018-12-31	2019-06-30	2019-09-30
Cash Operating	-0	-13	-19	5	-12	-26	-11	-6	4	-11	-2	-2		-320	-217	-183	-896	4			-502
Cash Investing	0													-287	-400	36	165	0			-152
Cash Financing	0	26	6	-5	12	27	10	6	4	2	2	2		724	832	-275	752	-93			533